Jounce Therapeutics, Inc.
Investors that purchased the Company’s securities and have suffered a loss, please fill in transaction information below, or email to info@portnoylaw.com.
There is no cost or obligation associated with submitting your information. If you are a shareholder who suffered a loss, please submit your contact information and purchase information to participate in the putative class action.
We also encourage you to contact Lesley F. Portnoy of The Portnoy Law Firm, at 310.692.8883, to discuss your rights free of charge. You can also reach us through the firm’s website at www.portnoylaw.com, or by email at info@portnoylaw.com.
If you choose to take no action, you can remain an absent class member.
Joining the case through the Portnoy Law website enables investors to learn about their legal claims and take an active role in recovering their losses.
The Portnoy Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
CONTACT:
Portnoy Law Firm
Lesley F. Portnoy, Esq.,
www.portnoylaw.com
Office: 310.692.8883
1800 Century Park East, Suite 600
Los Angeles, CA 90067
info@portnoylaw.com
The inquiry pertains to whether Jounce and its board of directors have breached their fiduciary obligations to shareholders and violated federal securities laws by neglecting to, among other things: (1) acquire the most favorable consideration for Jounce shareholders; (2) assess if Concentra is undervaluing Jounce; and (3) reveal all significant information that is necessary for Jounce shareholders to properly evaluate and appraise the merger proposal. Halper Sadeh LLC, acting on behalf of Jounce shareholders, may pursue better consideration for shareholders, more disclosures and data concerning the proposed deal, or other forms of relief and advantages.
